FDA inspection
Baxter Healthcare Corporation: FDA inspection ending Oct 16, 2001
FDA inspection 90936 · No Action Indicated (NAI) · New Providence, NJ
Key facts
| Inspection ID | 90936 |
|---|---|
| Firm | Baxter Healthcare Corporation |
| FEI number | 2212539 |
| Address | 95 Spring St |
| City | New Providence |
| State | NJ |
| ZIP | 07974-1143 |
| Fiscal year | 2002 |
| Inspection end date | Oct 16, 2001 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data